Fosamax Users Must Disclose Using Generic in MDL

Judge Rules Patients Must Disclose Use of Generic Fosamax in MDL A New York federal judge ruled on Wednesday, December 18th, 2013, that plaintiffs in a multidistrict litigation (MDL) against Teva Pharmaceuticals must disclose whether or not they had used a generic form of Fosamax for bone building, in order to back up claims that the generic … [Read more...]

Merck Proposes $27.7 Million in Fosamax Jaw Injury Litigation

Pharmaceutical Giant Agrees to Settle Fosamax Jaw Personal Injury Lawsuits On Monday, December 9th, pharmaceutical manufacturer Merck & Co, Inc agreed to pay $27.7 million to settle lawsuits from thousands of patients who allege that the bone-building drug Fosamax led to jaw bone deterioration. The settlement will resolve 1,140 lawsuits … [Read more...]

BestLawyers.comAVBetter Business Bureau